tirzepatide and mash Challenging the Dogma: Reversal of End-Stage Liver Fibrosis with in Cirrhosis 🔴 #SYNERGY_NASH Trial (NEJM, 2024)

In our Bay Area clinics, we offer a comprehensive medical weight loss program that is multipronged focusing on weight, NAD, blood sugar and glucose control, muscle building with creatine, and gut health with probiotics

doi:10.7759/cureus.29262 Drugs.com

GLP-1RA use was associated with a reduced risk of neurocognitive disorders (e.g., dementia and Alzheimers disease), seizures, thromboembolic disorders, pulmonary hypertension, chronic phlebitis, coagulopathy, and clotting disorders

These combined effects are why Retatrutide is being studied as part of next-generation weight loss drugs

are "compounded" rather than FDA-approved mass-market drugs